Position in HLN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$919,658
-$591,801 QoQ
Shares Held
98,570
-34.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#146
of 639 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Archford Capital Strategies, LLC holds $1,471,240 across 2 Drug Manufacturers - Specialty & Generic names. HLN ranks #1 (62.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
This page
|
98,570 | $919,658 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,018 | $551,582 |
All Filings in HLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $919,658 | 98,570 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $1,511,459 | 150,995 | Shares | Sole | 2026-04-15 | |
| 2025-09-30 | $2,148,566 | 239,528 | Shares | Sole | 2025-10-17 | |
| No filing history on record for this holder in this stock. | ||||||